Susan G Komen for the Cure

2 downloads 225 Views 1MB Size Report
Nov 18, 2010 - costs were primarily for The Race Series, informational materials, an internet website that includes fund
CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTAL SCHEDULES The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Years Ended March 31, 2010 and 2009 With Report of Independent Auditors

Ernst & Young LLP

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidated Financial Statements and Supplemental Schedules Years Ended March 31, 2010 and 2009

Contents Report of Independent Auditors.......................................................................................................1 Consolidated Financial Statements Consolidated Statements of Financial Position................................................................................2 Consolidated Statements of Activities .............................................................................................3 Consolidated Statements of Cash Flows ..........................................................................................4 Consolidated Statements of Functional Expenses ...........................................................................5 Notes to Consolidated Financial Statements....................................................................................7 Supplemental Schedules Consolidating Statement of Financial Position by Affiliate ..........................................................22 Consolidating Schedule of Revenue by Affiliate...........................................................................34 Consolidating Schedule of Functional Expenses by Affiliate .......................................................40

1009-1188665

Ernst & Young LLP One Victory Park Suite 2000 2323 Victory Avenue Dallas, TX 75219 Tel: +1 214 969 8000 Fax: +1 214 969 8587 www.ey.com

Report of Independent Auditors The Board of Directors The Susan G. Komen Breast Cancer Foundation, Inc. We have audited the accompanying consolidated statements of financial position of The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates (the Organization) as of March 31, 2010 and 2009, and the related consolidated statements of activities, cash flows, and functional expenses for the years then ended. These financial statements are the responsibility of the Organization’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Organization’s internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Organization’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates at March 31, 2010 and 2009, and the consolidated results of their operations and their cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States. Our audit was conducted for the purpose of forming an opinion on the 2010 consolidated financial statements taken as a whole. The accompanying consolidating statement of financial position by affiliate as of March 31, 2010, and the consolidating schedules of revenue by affiliate and functional expenses by affiliate for the year ended March 31, 2010, are presented for purposes of additional analysis and are not a required part of the 2010 consolidated financial statements. Such information has been subjected to the auditing procedures applied in our audit of the 2010 consolidated financial statements and, in our opinion, is fairly stated in all material respects in relation to the 2010 consolidated financial statements taken as a whole.

 November 18, 2010

1

1009-1188665 A member firm of Ernst & Young Global Limited

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidated Statements of Financial Position

March 31 2010

2009

Assets Cash and cash equivalents Investments (Note 2) Receivables, net (Note 3) Prepaid expenses and other assets Property and equipment, net (Note 1) Total assets

$ 245,448,321 $ 225,654,062 90,391,632 121,433,024 57,045,492 80,408,909 3,495,280 5,449,651 5,922,337 5,289,802 $ 458,029,707 $ 382,508,803

Liabilities and net assets Accounts payable, accrued expenses, and other payable Deferred revenue and rent Grants payable, net (Note 4) Total liabilities

$ 20,132,592 $ 9,788,369 3,310,513 6,080,613 247,125,219 268,585,300 260,224,101 294,798,505

Net assets (Note 5): Unrestricted – undesignated Unrestricted – board designated Total unrestricted Temporarily restricted Permanently restricted Total net assets Total liabilities and net assets

80,188,010 1,000,000 81,188,010 81,818,192 225,000 163,231,202 $ 458,029,707 $

50,827,177 1,000,000 51,827,177 70,232,525 225,000 122,284,702 382,508,803

See accompanying notes.

1009-1188665

2

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidated Statements of Activities

Unrestricted Public support and revenue: Contributions, sponsorships, and race entry fees Contributed goods and services (Note 1) Less direct benefits to donors and sponsors

Year Ended March 31, 2010 Temporarily Permanently Restricted Restricted

$ 272,971,918 $ 37,861,053 $ 56,873,320 17,145,063 (19,881,851) – 309,963,387 55,006,116 – – – – (43,420,449) 11,585,667

Total

Unrestricted

Year Ended March 31, 2009 Temporarily Permanently Restricted Restricted

Total

– $ 310,832,971 $ 268,676,237 $ 32,652,454 $ – 74,018,383 49,644,892 15,017,229 – (19,881,851) (19,965,382) – – 364,969,503 298,355,747 47,669,683

– $ 301,328,691 – 64,662,121 – (19,965,382) – 346,025,430

– – – – – –

4,180,705 (960,185) 26,261,770 6,443,560 – 400,895,353

6,785,366 (7,891,568) (22,762,250) 4,722,658 52,118,461 331,328,414

– – – – –

6,785,366 (7,891,568) (22,762,250) 4,722,658 – 326,879,636

– – – – (52,118,461) (4,448,778)

Interest and dividends Net realized losses on investments Net unrealized gains (losses) on investments Other Net assets released from restrictions Total public support and revenue

4,180,705 (960,185) 26,261,770 6,443,560 43,420,449 389,309,686

Expenses: Program services: Research Public health education Health screening services Treatment services Total program services

75,407,069 140,773,507 46,860,822 20,137,769 283,179,167

– – – – –

– – – – –

75,407,069 140,773,507 46,860,822 20,137,769 283,179,167

70,146,688 135,529,669 39,653,265 22,329,648 267,659,270

– – – – –

– – – – –

70,146,688 135,529,669 39,653,265 22,329,648 267,659,270

36,145,613 40,624,073 76,769,686

– – –

– – –

36,145,613 40,624,073 76,769,686

29,495,530 37,148,160 66,643,690

– – –

– – –

29,495,530 37,148,160 66,643,690

359,948,853





359,948,853

334,302,960





334,302,960

Supporting services: Fund-raising costs General and administrative Total supporting services Total expenses Change in net assets Net assets at beginning of year Net assets at end of year

29,360,833 11,585,667 51,827,177 70,232,525 $ 81,188,010 $ 81,818,192 $

– 40,946,500 225,000 122,284,702 225,000 $ 163,231,202

(2,974,546) (4,448,778) 54,801,723 74,681,303 $ 51,827,177 $ 70,232,525 $

– (7,423,324) 225,000 129,708,026 225,000 $ 122,284,702

See accompanying notes.

3

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidated Statements of Cash Flows

Year Ended March 31 2010 2009 Operating activities Change in net assets Adjustments to reconcile change in net assets to net cash provided by operating activities Depreciation and amortization Net unrealized (gains) losses on investments Net loss on disposals of property and equipment (Increase) decrease in receivables, net Increase in prepaid expenses and other assets Increase (decrease) in accounts payable and accrued expenses Increase in deferred revenue and rent Increase in grants payable, net Net cash provided by operating activities Investing activities Purchases of property and equipment Proceeds from disposals of property and equipment Purchases of investments Sales and maturities of investments Net cash used in investing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year

$ 40,946,500 $ (7,423,324)

2,014,354 (26,261,770) – (23,363,417) (1,954,371)

1,152,113 22,762,250 123,499 8,044,182 (445,937)

10,344,223 2,770,100 21,460,081 25,955,700

(2,230,565) 325,152 1,670,090 23,977,460

(4,401,470) (1,381,819) 3,354 – (51,884,116) (100,817,623) 64,957,292 47,104,494 (6,161,441) (40,258,447) (16,280,987) 19,794,259 241,935,049 225,654,062 $ 245,448,321 $ 225,654,062

See accompanying notes.

1009-1188665

4

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidated Statements of Functional Expenses Year Ended March 31, 2010

Research Marketing and communications (primarily contributed goods and services) Salaries and benefits Supplies Postage and shipping Occupancy Equipment rental Conferences, conventions, and meetings Printing and publications Awards and grants Professional fees Travel Taxes Race series production Bank fees Telephone Depreciation and amortization Miscellaneous Total expenses before direct benefits to donors and sponsors Direct benefits to donors and sponsors Total expenses

5

$

Program Services Health Public Health Screening Education Services

1,920,918 $ 42,088,570 $ 2,774,422 19,375,214 12,288 1,250,421 19,103 3,161,092 255,509 2,653,094 299,567 2,639,852 338,101 32,752 62,691,301 6,315,130 260,008 19,580 58,068 40,233 35,796 120,866 213,427

2,405,008 5,488,816 29,660,285 19,008,361 2,393,446 30,526 6,832,695 783,838 527,023 304,361 2,170,905

24,573 $ 1,419,408 24,676 14,911 116,412 49,780 87,007 26,594 44,827,098 163,050 34,746 703 8,715 8,723 25,765 9,160 19,501

Supporting Services Fund-Raising Costs General and Administrative Treatment Services

5,120 679,442 13,169 7,335 67,946 28,467 36,406 14,579 19,143,346 94,801 13,011 277 6,182 2,045 11,491 4,309 9,843

75,407,069 140,773,507 46,860,822 20,137,769 – – – – $ 75,407,069 $ 140,773,507 $ 46,860,822 $ 20,137,769

Race for the Cure

$

Other FundRaising

9,036,299 $ 958,546 204,431 20,934 363,988 554,508

4,945,468 $ 1,603,113 201,003 2,234,104 177,135 182,469

87,443 46,832 – 1,249,329 99,441 9,008 1,662,675 2,038,679 45,312 5,693 6,178

255,109 3,702,228 – 4,416,656 163,359 5,015 411,115 457,823 48,044 39,520 914,156

16,389,296 19,756,317 17,645,393 2,236,458 $ 34,034,689 $ 21,992,775 $

Affiliate Relations

Other

Total

3,368 $ 2,132,067 $ 60,156,383 2,121,818 15,942,123 44,874,086 8,206 410,969 2,125,163 13,489 227,869 5,698,837 134,050 2,252,049 6,020,183 71,712 3,005,499 6,831,854 140,104 13,701 – 431,913 299,332 (49) 119 10,746 29,387 15,423 429,599

568,998 443,755 – 6,460,556 997,011 128,607 707,237 614,296 355,634 1,515,022 1,139,463

3,918,176 9,769,257 156,322,030 38,139,796 4,260,354 193,667 9,686,806 3,956,383 1,078,452 2,014,354 4,903,072

3,722,918 36,901,155 359,948,853 – – 19,881,851 3,722,918 $ 36,901,155 $ 379,830,704

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidated Statements of Functional Expenses (continued) Year Ended March 31, 2009

Research Marketing and communications (primarily contributed goods and services) Salaries and benefits Supplies Postage and shipping Occupancy Equipment rental Conferences, conventions, and meetings Printing and publications Awards and grants Professional fees Travel Taxes Race series production Bank fees Telephone Depreciation and amortization Miscellaneous Total expenses before direct benefits to donors and sponsors Direct benefits to donors and sponsors Total expenses

$

802,851 $ 37,398,884 $ 2,808,667 11,620,179 5,310 763,585 29,627 2,962,607 128,708 1,608,487 156,933 1,727,227 207,636 41,148 59,179,051 6,042,944 357,857 29,463 – 40,019 38,618 72,688 205,168

Supporting Services Fund-Raising Costs General and Administrative

Program Services Health Public Health Screening Education Services

1,584,438 4,966,506 46,705,425 13,559,743 2,485,256 57,404 6,187,799 766,910 281,317 139,813 2,714,089

Treatment Services – $ – – – – –

– – 39,653,265 – – – – – – – –

Race for the Cure – – – – – –

– – 22,329,648 – – – – – – – –

70,146,688 135,529,669 39,653,265 22,329,648 – – – – $ 70,146,688 $ 135,529,669 $ 39,653,265 $ 22,329,648

Other FundRaising

$ 10,021,017 $ 810,151 225,632 490,619 308,040 355,650 60,929 436,967 – 1,761,486 106,638 16,222 1,704,860 1,549,615 28,702 9,204 242,833

997,684 $ 1,390,963 281,703 2,377,201 97,293 171,476 114,570 3,735,070 – 822,345 75,690 5,740 68,749 260,570 19,961 13,239 934,711

18,128,565 11,366,965 17,865,109 2,100,273 $ 35,993,674 $ 13,467,238 $

Affiliate Relations

Other

Total

746,105 $ 4,124,777 $ 54,091,318 1,914,581 13,932,901 32,477,442 9,538 608,821 1,894,589 15,117 424,281 6,299,452 123,342 1,934,926 4,200,796 68,934 1,220,094 3,700,314 73,874 12,152 – 511,656 208,830 12,868 – 11,924 27,520 11,765 45,016

468,094 414,738 – 5,371,092 1,107,055 185,046 25,785 539,345 369,880 905,404 1,722,699

2,509,541 9,606,581 167,867,389 28,069,266 4,341,326 306,743 7,987,193 3,168,383 765,998 1,152,113 5,864,516

3,793,222 33,354,938 334,302,960 – – 19,965,382 3,793,222 $ 33,354,938 $ 354,268,342

See accompanying notes.

6

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements March 31, 2010

1. General Information and Summary of Significant Accounting Policies General Information The Susan G. Komen Breast Cancer Foundation, Inc. doing business as Susan G. Komen for the Cure and Affiliates (the Organization), a Texas not-for-profit corporation, was incorporated in July 1982. The primary mission of the Organization is to eradicate breast cancer as a lifethreatening disease by advancing research, education, screening, and treatment. Research advancement is achieved through relationships with medical and cancer centers throughout the United States, as well as internationally. Treatment and screening programs, primarily funded through the Organization’s Affiliates, produce affordable treatment and screening for the medically underserved and other target populations. The Organization’s reach has expanded tremendously since its inception, due in large part to the Komen Race for the Cure® Series (The Race Series) and other fund-raising programs and events, as well as the Organization’s many donors, corporate partners, and educational initiatives and materials. As a result of this heightened awareness of breast cancer, millions have received the life-saving message of early detection. The consolidated financial statements of the Organization include the activity of the Organization’s International Headquarters, the Susan G. Komen for the Cure Advocacy Alliance (the Alliance), and 123 and 122 Affiliates in 2010 and 2009, respectively. All significant intercompany accounts have been eliminated in the accompanying consolidated financial statements. The Race Series, a series of 5K and one-mile walk/runs, was held in 119 and 116 cities across the United States during 2010 and 2009, respectively, and is the Organization’s primary source of revenues. Up to 75% of the net proceeds generated by the Affiliates are used to fund breast cancer education, treatment, and screening projects within local communities. The remaining 25% is used to fund breast cancer research and project grants on a national level.

1009-1188665

7

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

1. General Information and Summary of Significant Accounting Policies (continued) The following is a list of Affiliates included in the accompanying consolidated financial statements. Acadiana Arkansas Aspen Austin Baton Rouge Bayou Region Boise Brainerd Lakes Central & South Jersey Central Florida Central Georgia Central MS Steel Magnolias Central New Mexico Central New York Central Oklahoma Central Texas Central Valley Central Wisconsin Charlotte Chattanooga Chicagoland Area Coastal Georgia Coeur d’Alene Colorado Springs Columbus Connecticut Dallas County Denver Metropolitan Des Moines Eastern Washington El Paso Elmira

Florida Suncoast Grand Rapids Greater Amarillo Greater Atlanta Greater Cincinnati Greater Evansville Greater Kansas City Greater Lansing Greater Nashville Greater New York City Greater Richmond Greater Roanoke Hawaii Houston Indianapolis Inland Empire Knoxville Las Vegas Lexington Los Angeles County Louisville Lowcountry (Charleston) Lubbock Area Madison Maine Maryland Massachusetts McLean County Memphis Mid-South Miami-Ft. Lauderdale Mid-Kansas Mid-Missouri

Milwaukee Minnesota Montana NC Foothills NC Triad NC Triangle Nebraska New Orleans North Central Alabama North Colorado North Dakota North Florida North Jersey North Mississippi North Texas Northeast Louisiana Northeast Ohio Northeast Pennsylvania Northeastern New York Northern Indiana Northern Nevada Northwest Ohio Orange County Oregon & SW Washington Ozark Peoria Memorial Philadelphia Phoenix Pittsburgh Puget Sound Quad Cities Sacramento Valley

Salt Lake City San Antonio San Diego San Francisco Bay Area Shreveport-Bossier City Siouxland South Dakota South Florida Southeast Iowa Southern Arizona Southwest Florida Southwest Michigan St. Louis Tarrant County Texarkana Tidewater Tri Cities Tulsa Tyler Upper Cumberland Upstate South Carolina Vermont-New Hampshire Wabash Valley West Virginia Western New York Wichita Falls Wyoming

During fiscal year 2008, the Organization formed the Alliance under Section 501(c)(4) of the Internal Revenue Code (the Code). The Alliance was established to enhance the Organization’s public policy efforts.

1009-1188665

8

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

1. General Information and Summary of Significant Accounting Policies (continued) International Affiliates of the Organization operate in Italy, Germany, and Puerto Rico under three separate International Affiliate Agreements. The financial statements of the three international Affiliates are not included in the consolidated financial statements since the Organization does not currently exercise economic or board controlling interests over any of the these Affiliates. In 2009, the Organization was the net beneficiary of the Breast Cancer 3-Day, a project of the National Philanthropic Trust (NPT), an independent nonprofit organization. The Breast Cancer 3-Day is a series of three-day walks that raise funds for the fight against breast cancer. The combination of the events is considered “The 3-Day Series.” NPT was the event manager for The 3-Day Series. As the primary beneficiary, the Organization received 85% of the net proceeds to support breast cancer research, education, screening, and treatment programs. The remaining 15% of the net proceeds was directed to the NPT Breast Cancer Fund, a special interest fund for breast cancer initiatives. Fourteen events took place during 2009 with net proceeds of $54,600,000, and is included as a contribution in contributions, sponsorships, and race entry fees in the accompanying consolidated statements of activities. On January 1, 2010, the Organization assumed responsibility for managing the operations of the Breast Cancer 3-Day 2010 Race Series. Beginning January 1, 2010, the revenues and expenses are included in the consolidated financial statements of the Organization for the operations directly related to the 2010 series. Basis of Presentation The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States for not-for-profit organizations. Under these provisions, net assets and revenues, gains, and losses are classified based on the existence or absence of donor-imposed restrictions. Expenses are classified as unrestricted. Accordingly, net assets of the Organization and changes therein are classified and reported as follows: •

Unrestricted net assets – Net assets that are not subject to donor-imposed stipulations. Unrestricted net assets may be designated for specific purposes by action of the Board of Directors.

1009-1188665

9

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

1. General Information and Summary of Significant Accounting Policies (continued) •

Unrestricted net assets – board designated – Unrestricted net assets designated by the Board of Directors as restricted for mission expenditures.



Temporarily restricted net assets – Net assets subject to donor-imposed stipulations that will be met either by actions of the Organization and/or the passage of time. When a restriction is satisfied or expires, temporarily restricted net assets are reclassified to unrestricted net assets and reported in the consolidated statement of activities as net assets released from restrictions. Contributions received with donor-imposed restrictions that are met in the same year as received are reported as revenues of the unrestricted net asset class.



Permanently restricted net assets – Net assets subject to donor-imposed stipulations that may be maintained permanently by the Organization. Generally, the donors of these assets permit the Organization to use all or part of the income earned on related investments for general or specific purposes.

The Organization prepares a Statement of Financial Position, Statement of Activities, and Statement of Cash Flows as the required financial statements for not-for-profit organizations. The statement of Functional Expenses for 2009 and 2010 is also included as a supplement to the required financial statements. The Organization reports gifts of property and equipment as unrestricted support unless explicit donor stipulations specify how the donated assets must be used. Gifts of long-lived assets with explicit restrictions that specify how the assets are to be used and gifts of cash or other assets that must be used to acquire long-lived assets are reported as temporarily restricted revenue. Absent explicit donor stipulations about how long those long-lived assets must be maintained, the Organization reports expirations of donor restrictions when the donated or acquired long-lived assets are placed in service. Contributed Goods and Services Total contributed goods and services for the years ended March 31, 2010 and 2009, were approximately $74,018,000 and $64,662,000, respectively, and primarily relate to local television, radio, and newspaper advertising for The Race Series and 3-Day Series events. Contributed materials and equipment are reported as contributions in the accompanying

1009-1188665

10

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

1. General Information and Summary of Significant Accounting Policies (continued) consolidated financial statements at their estimated fair values at date of receipt. Contributed services are reported in the accompanying consolidated financial statements at the fair value of the services received. The contribution of services is recognized if the services received (a) create or enhance nonfinancial assets or (b) require specialized skills that are provided by individuals possessing those skills and would typically need to be purchased if not provided by donation. In addition, the Organization receives services from a large number of volunteers who give significant amounts of their time to the Organization’s programs, fund-raising campaigns, and management. No amounts have been reflected for these types of donated services, as they do not meet the criteria outlined above. Amounts Per Consolidated Financial Statements Year Ended March 31, 2010 Public support and revenue Less: Komen Race for the Cure direct costs Net public support and revenue Expenses: Supporting services Program services Total expenses Change in net assets

$

$

Program services % of total expense Year Ended March 31, 2009 Public support and revenue Less: Komen Race for the Cure direct costs Net public support and revenue Expenses: Supporting services Program services Total expenses Change in net assets Program services % of total expense

1009-1188665

Value of In-Kind Contributed Goods and Services

420,777,204 $

74,018,383 $

346,758,821

(19,881,851) 400,895,353

(9,721,786) 64,296,597

(10,160,065) 336,598,756

76,769,686 283,179,167 359,948,853 40,946,500 $

16,079,334 36,054,307 52,133,641 12,162,956 $

60,690,352 247,124,860 307,815,212 28,783,544

79%

$

$

Net Without In-Kind

69%

80%

346,845,018 $

64,662,121 $

282,182,897

(19,965,382) 326,879,636

(8,862,717) 55,799,404

(11,102,665) 271,080,232

66,643,690 267,659,270 334,302,960 (7,423,324) $

21,921,021 33,024,791 54,945,812 853,592 $

44,722,669 234,634,479 279,357,148 (8,276,916)

80%

60%

84%

11

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

1. General Information and Summary of Significant Accounting Policies (continued) Contributions Contributions, including unconditional promises to give, are recorded when received or pledged. All contributions are available for unrestricted use unless specifically restricted by the donor. Conditional promises to give are recognized when the conditions on which they depend are substantially met. Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand and all highly liquid investments with a remaining maturity of three months or less when purchased. Investments and Investment Revenue Recognition Investments in equity securities with readily determinable fair values and all investments in debt securities are reported at fair value. Investment income includes dividends and interest and is recognized as revenue in the period in which it is earned. The amounts are reported as an increase in unrestricted net assets unless otherwise restricted by the donor. Realized and unrealized gains and losses on investments are classified and recorded as increases or decreases in unrestricted net assets, unless otherwise restricted by the donor. Property and Equipment Purchased property and equipment is carried at cost. Donated property and equipment is recorded at market value at date of donation. The Organization capitalizes all expenditures for property and equipment in excess of $10,000, which is comprised of computers, office equipment, furniture, fixtures, and leasehold improvements. As of March 31, 2010, accumulated amortization of intangible assets totaled approximately $1,788,000.

1009-1188665

12

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

1. General Information and Summary of Significant Accounting Policies (continued) Property and equipment are depreciated on a straight-line basis over the following periods: •

Furniture and fixtures

5-7 years



Equipment

3-5 years



Software

3-5 years



Leasehold improvements

Estimated life of the asset or the lease term (whichever is shorter)



Intangible assets

5-7 years

Property and equipment and related accumulated depreciation and amortization are as follows: 2010 Equipment Furniture and fixtures Leasehold improvements Software Intangible assets Total property and equipment Accumulated depreciation and amortization Net property and equipment

2009

$ 5,399,805 $ 5,395,267 2,080,582 2,609,973 1,001,167 1,021,924 3,565,276 3,918,977 3,540,912 3,540,912 15,583,204 16,491,591 (11,201,789) (9,660,867) $ 5,289,802 $ 5,922,337

Inventories Inventories are stated at the lower of cost or market determined by the first-in, first-out method and consist of educational materials, along with branded merchandise held for use in program services and sales to unrelated parties. Inventories are included in prepaid expenses and other assets in the accompanying consolidated statements of financial position and totaled approximately $878,000 and $1,179,000 in 2010 and 2009, respectively.

1009-1188665

13

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

1. General Information and Summary of Significant Accounting Policies (continued) Market and Credit Risk Concentrations The Organization’s investments do not have a significant concentration of credit or market risk within any industry, specific institution, or group of investments. Cash balances over $250,000 for each account are not covered by FDIC insured limits, but the Organization does not believe there is significant credit or market risk associated with these amounts. Deferred Revenue Resources received in exchange transactions are recognized as deferred revenue to the extent that the earnings process has not been completed. These resources are recorded as unrestricted revenues when the related obligations have been satisfied. Functional Allocation of Expenses The costs of providing the Organization’s various programs and other activities have been summarized on a functional basis. Accordingly, certain costs have been allocated among the programs and supporting services benefited. Advertising Expenses The Organization recorded advertising expense of approximately $60,200,000 and $54,100,000 for the years ended March 31, 2010 and 2009, respectively. The majority of advertising was contributed and is included in marketing and communications at International Headquarters. Other advertising costs are incurred as they relate to the 3 Day Series and other Race for the Cure events and are included with all advertising costs in the consolidated statements of functional expense. Advertising costs were previously expensed upon first showing and in 2010 were expensed over the duration of the advertising campaign. This change in accounting policy does not have a material impact on prior periods.

1009-1188665

14

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

1. General Information and Summary of Significant Accounting Policies (continued) Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Recent Accounting Pronouncements The Organization defines subsequent events as events or transactions that occur after the statement of financial position date, but before the financial statements are issued or available to be issued. Subsequent events are recognized in two categories: recognized subsequent events, which provide additional evidence about conditions that existed at the balance sheet date and nonrecognized subsequent events, which provide evidence about conditions that did not exist as of the balance sheet date, but arose after that date. Recognized subsequent events are required to be disclosed. Management has evaluated subsequent events through November 18, 2010, which is the date the financial statements were available to be issued and no events have occurred from the balance sheet date that would impact the consolidated financial statements. 2. Investments Investments are recorded on a three-level hierarchy for disclosure of fair value measurements. The valuation hierarchy is based on the transparency of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows: •

Level 1 – inputs to the valuation methodology are quoted prices for identical assets and liabilities in active markets.



Level 2 – inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.



Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement.

1009-1188665

15

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

2. Investments (continued) A financial instrument’s categorization within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Organization’s investments are valued at quoted prices available in an active market and are classified within Level 1 of the valuation hierarchy. At March 31, 2010 and 2009, the Organization’s financial instruments included cash and cash equivalents, receivables, accounts payable and accrued expenses, and grants payable. The carrying amounts reported in the accompanying consolidated statements of financial position for these financial instruments approximate their fair values. The Organization incurred investment expenses of approximately $272,000 and $214,000 in fiscal years 2010 and 2009, respectively, which are included in professional fees in the accompanying consolidated statements of functional expenses. Investments at March 31, 2010 and 2009, were comprised of the following: 2010 Domestic common stock International common stock International equity fund Corporate bonds Fixed income funds Government bonds Certificates of deposit Total

2009

Cost

Fair Value

Cost

Fair Value

$ 44,469,571 8,578,930 8,000,000 21,529,077 23,315,339 – 12,498,409 $ 118,391,326

$ 45,229,264 9,059,411 6,812,139 22,682,467 25,151,334 – 12,498,409 $ 121,433,024

$ 42,449,588 6,980,992 8,000,000 18,883,497 17,734,508 114,653 19,288,032 $ 113,451,270

$ 28,256,023 4,899,676 4,625,803 17,967,957 15,233,578 114,653 19,293,942 $ 90,391,632

3. Receivables Net receivables were approximately $80,409,000 and $57,045,000 at March 31, 2010 and 2009, respectively. Receivables that are expected to be collected within one year are recorded at net realizable value. Receivables that are expected to be collected in future years are recorded at the present value of their estimated future cash flows. The discounts on those amounts are computed using risk-free interest rates applicable to the years in which the agreements are expected to be satisfied (0.41% to 3.04% at March 31, 2010). The discount as of March 31, 2010 and 2009, was approximately $723,000 and $787,000, respectively. The allowance for doubtful accounts was approximately $1,730,000 and $480,000 as of March 31, 2010 and 2009, respectively.

1009-1188665

16

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

3. Receivables (continued) Future annual receivables, net as of March 31, 2010, are as follows: 2011 2012 2013 2014 2015 Thereafter Total

$ 64,282,031 8,521,241 4,867,759 948,835 917,982 871,061 $ 80,408,909

The Race Series receivables were approximately $35,793,000 and $27,381,000 at March 31, 2010 and 2009, respectively. These receivables primarily represent promises to give from national and local race sponsors who committed support prior to March 31. Unconditional promises to give by donors of approximately $44,616,000 and $22,017,133 at March 31, 2010 and 2009, respectively, are expected to be received by the Organization over periods ranging from one to six years, with the majority of the balances due within one year. In fiscal year 2009, the Organization loaned $7,600,000 to the NPT Breast Cancer 3-Day to fund start-up costs for the 2009 calendar year 3-Day Series. The note was fully paid in June 2009.

1009-1188665

17

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

4. Grants Payable As of March 31, 2010 and 2009, the Organization made grants to various medical and cancer centers for research, education, screening, and treatment. These agreements are subject to periodic reporting and compliance requirements and can be rescinded by the Organization for breach. Grants payable in more than one year are discounted to their present values as of March 31, 2010, at rates ranging from 0.41% to 2.55%. The grants payable at March 31, 2010, are scheduled for payment in the following fiscal years: Year ending March 31: 2011 2012 2013 2014 2015 Total grants payable Less unamortized discount Grants payable, net

$ 187,837,889 43,471,415 30,600,900 7,317,952 1,417,222 270,645,378 (2,060,078) $ 268,585,300

The Organization generally funds its obligations under these arrangements from cash flow from operations and available cash and cash equivalent and investment balances. 5. Net Assets Temporarily restricted net assets as of March 31, 2010 and 2009, are categorized as follows: 2010 Restricted for grants Time restrictions

2009

3,442,979 $ 1,580,286 68,652,239 78,375,213 $ 81,818,192 $ 70,232,525 $

Permanently restricted net assets represent endowed gifts to be held in perpetuity with the investment income to be used for breast cancer research fellowships, breast cancer educational programs, and research awards.

1009-1188665

18

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

6. Joint Costs The accompanying consolidated statements of activities include joint activities (activities benefiting multiple programs and/or supporting services) that include fund-raising. The joint costs were primarily for The Race Series, informational materials, an internet website that includes fund-raising, and direct mail campaigns. The cost of conducting those joint activities was allocated as follows in fiscal 2010 and 2009: 2010 Research Public health education General and administrative Fund-raising

2009

393,342 729,612 $ 61,234,453 64,920,135 6,729,585 5,544,098 23,840,296 28,983,945 $ 100,177,790 $ 92,197,676 $

7. Leases The Organization has operating lease agreements for office space and electrical costs. Total rent expense was approximately $5,700,000 and $4,200,000 for fiscal years 2010 and 2009, respectively. Future annual minimum lease payments due under noncancelable operating leases as of March 31, 2010, are as follows: 2011 2012 2013 2014 2015 Thereafter Total

$

3,079,382 2,826,068 2,682,029 2,096,924 1,306,328 4,750,231 $ 16,740,962

8. Federal Income Taxes The Organization is a tax-exempt entity under Section 501(a) of the Internal Revenue Code (the Code) under a determination letter issued by the Internal Revenue Service (IRS). The Affiliates of the Organization have a separate group determination letter, under the umbrella of the Organization’s exemption, recognizing their exempt status under Section 501(a) of the Code.

1009-1188665

19

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

8. Federal Income Taxes (continued) Further, the Organization has been classified as an organization that is not a private organization under Section 509(a) of the Code, and as such, contributions to the Organization qualify for deduction as charitable contributions. However, income generated from activities unrelated to the Organization’s exempt purpose is subject to tax under Section 511 of the Code. The Organization did not have any unrelated business income for the years ended March 31, 2010 and 2009. Therefore, no tax liability has been provided in the accompanying consolidated financial statements. On October 16, 2007, the Organization formed the Alliance, a social welfare organization, under Section 501(a) of the Code. Under Section 501(a), a social welfare organization is not subject to monetary limitations on lobbying expenditures that further its exempt purpose. The Alliance is a tax-exempt entity described in Section 501(c)(4) of the Code under a determination letter issued by the IRS. The Organization is a nonprofit corporation and has been recognized as tax-exempt pursuant to Section 501(a) of the Code, as an entity described in Section 501(c)(3). The Organization is subject to federal and state income tax on any taxable income generated from unrelated business activities. Under a new accounting pronouncement, the Organization is subject to a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Organization adopted the provisions of this new pronouncement effective April 1, 2008. There were no uncertain tax positions recorded in the financial statements at March 31, 2010 or March 31, 2009. 9. Retirement Plan The Organization has a defined contribution retirement plan under the provisions of Section 403(b) (the 403(b) Plan) of the Code. The Organization matches employee contributions up to 6% of employees’ annual salary. All employees are eligible to make deferrals immediately. However, participants are not eligible to receive the employer matching contribution until after one year of continuous employment. The 403(b) Plan expense was approximately $855,000 and $614,000 for the years ended March 31, 2010 and 2009, respectively.

1009-1188665

20

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Notes to Consolidated Financial Statements (continued)

9. Retirement Plan (continued) The Organization has a non-qualified deferred compensation plan subject to the provisions of Section 457 of the Code (the 457 Plan). The 457 Plan is maintained primarily for certain members of management. Funding is at the discretion of the Board of Directors. In fiscal year 2009, $10,000 was withdrawn. There were no amounts funded in 2009 or 2010.

1009-1188665

21

Supplemental Schedules

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Statement of Financial Position by Affiliate March 31, 2010

Affiliate Name Acadiana Arkansas Aspen Austin Baton Rouge Bayou Region Boise Brainerd Lakes Central Florida Central Georgia Central MS Steel Magnolias Central New Mexico Central New York Central Oklahoma Central & South Jersey Central Texas Central Valley Central Wisconsin Charlotte Chattanooga Chicagoland Area Coastal Georgia Coeur d’ Alene Colorado Springs

22

Cash and Cash Equivalents $

627,532 270,385 573,574 2,004,758 744,848 220,850 305,476 186,789 1,053,794 318,937 373,293 368,760 812,081 1,039,863 2,398,206 388,087 621,941 176,600 970,988 339,551 908,179 218,284 255,373 795,161

Investments $

– 798,190 1 – – – 232,110 – – – – – – – – – – – 740,604 – 1,240,000 – 20,073 –

Receivables, Net

Prepaid Property and Expenses and Equipment, Other Assets Net

$

$

23,025 55,406 9,164 65,525 58,753 37,795 204,951 7,639 73,709 10,937 162,098 20,356 68,950 60,311 115,309 419,467 24,520 44,761 97,816 15,601 734,801 59,854 7,780 22,524

912 463 8,401 – – – 7,727 6,964 749 2,424 1,198 1,547 2,065 – 7,115 1,574 3,939 – 2,520 5,683 – 4,059 3,997 11,223

$

– 5,669 – 1,425 – – 760 1,828 17,249 – – 1,157 2,856 1,870 13,532 – – – 1,753 – 678 – – –

Total Assets $

651,469 1,130,113 591,140 2,071,708 803,601 258,645 751,024 203,220 1,145,501 332,298 536,589 391,820 885,952 1,102,044 2,534,162 809,128 650,400 221,361 1,813,681 360,835 2,883,658 282,197 287,223 828,908

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Statement of Financial Position by Affiliate (continued) March 31, 2010

Affiliate Name Columbus Connecticut Denver Metropolitan Dallas County Des Moines Eastern Washington Elmira El Paso Florida Suncoast Grand Rapids Greater Amarillo Greater Atlanta Greater Cincinnati Greater Evansville Greater Kansas City Greater Lansing Greater Nashville Greater New York City Greater Richmond Greater Roanoke Hawaii Houston Indianapolis Inland Empire

23

Cash and Cash Equivalents $

2,489,773 1,428,847 3,969,224 1,911,413 964,710 545,835 166,735 705,032 1,472,747 296,548 433,077 3,329,638 1,265,391 782,277 1,173,031 680,216 610,734 6,150,700 781,494 364,253 443,284 4,126,037 1,985,439 814,210

Investments $

– – 784,259 1,000,000 – 203,009 – – 500,572 300,921 – – – – – – 443,000 – – – – 617,147 507,351 116,657

Receivables, Net

Prepaid Property and Expenses and Equipment, Other Assets Net

$

$

389,938 245,937 1,660,904 258,054 295,375 132,356 61,605 139,884 166,777 57,124 10,960 796,953 49,449 129,537 133,773 241,004 55,267 155,927 184,009 60,774 23,123 163,498 758,098 55,151

1,000 17,532 18,673 7,935 1,999 3,117 548 – 2,217 2,151 5,053 3,941 – – 2,000 – 7,424 204,289 2,025 – 1,899 5,122 – 1,587

$

5,227 – 14,066 3,309 5,603 – 829 1,330 – 1,452 453 8,040 1,783 1,229 505 2,305 472 33,649 1,938 – – – 1,425 2,004

Total Assets $

2,885,938 1,692,316 6,447,126 3,180,711 1,267,687 884,317 229,717 846,246 2,142,313 658,196 449,543 4,138,572 1,316,623 913,043 1,309,309 923,525 1,116,897 6,544,565 969,466 425,027 468,306 4,911,804 3,252,313 989,609

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Statement of Financial Position by Affiliate (continued) March 31, 2010

Affiliate Name Knoxville Las Vegas Lexington Los Angeles County Louisville Lowcountry (Charleston) Lubbock Area Madison Maine Maryland Massachusetts McLean County Memphis Mid-South Miami – Ft. Lauderdale Mid-Kansas Mid-Missouri Milwaukee Minnesota Montana NC Foothills NC Triad NC Triangle Nebraska New Orleans

24

Cash and Cash Equivalents $

747,513 1,433,014 678,802 1,015,109 889,576 571,250 535,068 820,271 502,200 2,500,013 1,151,558 225,643 994,769 1,974,269 1,164,376 120,073 2,545,419 2,368,003 309,999 146,005 967,855 1,693,083 955,496 757,023

Investments $

53,256 – – 15,102 101,996 311,992 – 250,000 – 851,038 286,342 – – – – 103,865 – – 47,381 65,702 – 3,293 – –

Receivables, Net

Prepaid Property and Expenses and Equipment, Other Assets Net

$

$

27,990 573,351 37,433 733,864 32,949 72,059 65,077 421,903 46,679 581,583 181,404 6,883 37,379 127,594 83,343 28,703 1,355,239 745,101 54,077 10,459 343,158 1,094,487 48,567 14,555

– – 14,786 18,270 10,953 4,493 13,184 – 903 – 6,299 – 250 4,425 8,575 – 562 – 232 – 350 5,086 3,416 451

$

2,875 425 1,124 1,316 1,407 809 5,265 – – 4,454 4,208 – 1 10,079 800 2,571 1,353 – 215 756 31,525 16,006 28,084 2,229

Total Assets $

831,634 2,006,790 732,145 1,783,661 1,036,881 960,603 618,594 1,492,174 549,782 3,937,088 1,629,811 232,526 1,032,399 2,116,367 1,257,094 255,212 3,902,573 3,113,104 411,904 222,922 1,342,888 2,811,955 1,035,563 774,258

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Statement of Financial Position by Affiliate (continued) March 31, 2010

Affiliate Name North Central Alabama North Colorado North Dakota North Florida North Jersey North Mississippi North Texas Northeast Louisiana Northeastern New York Northern Indiana Northern Nevada Northeast Ohio Northeast Pennsylvania Northwest Ohio Orange County Oregon & SW Washington Ozark Peoria Memorial Philadelphia Phoenix Pittsburgh Puget Sound Quad Cities Sacramento Valley

25

Cash and Cash Equivalents $

917,543 – 153,066 363,264 2,123,110 189,443 1,076,304 239,139 360,882 275,910 486,705 1,994,017 608,325 564,038 2,572,809 2,307,207 1,174,319 882,280 5,022,605 2,638,832 2,349,676 1,293,880 333,953 1,753,593

Investments $

– – – – – – 97,386 – – – – 251,051 – 401,235 – 516,774 205,765 645,635 – – 50,210 2,560,187 – –

Receivables, Net

Prepaid Property and Expenses and Equipment, Other Assets Net

$

$

39,412 – 6,962 37,660 1,143,102 5,571 567,936 1,462 22,618 49,005 26,286 222,151 27,376 164,272 639,976 2,315,697 549,767 377,300 2,239,295 152,579 568,048 827,771 287,704 840,306

– – – 12,176 25,044 – 21,451 – 948 200 31,734 2,100 – – 18,086 28,059 2,538 4,592 2,259 18,465 40,920 25,168 96 503

$

500 – – – 23,401 1,349 828 – 750 888 1 16,835 119 – 5,121 19,461 2,222 1,025 36,422 2,429 655 59,257 – 852

Total Assets $

957,455 – 160,028 413,100 3,314,657 196,363 1,763,905 240,601 385,198 326,003 544,726 2,486,154 635,820 1,129,545 3,235,992 5,187,198 1,934,611 1,910,832 7,300,581 2,812,305 3,009,509 4,766,263 621,753 2,595,254

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Statement of Financial Position by Affiliate (continued) March 31, 2010

Affiliate Name Salt Lake City San Antonio San Diego San Francisco Bay Area Shreveport – Bossier City Siouxland South Dakota South Florida Southeast Iowa Southern Arizona Southwest Florida Southwest Michigan St. Louis Tarrant County Texarkana Tidewater Tri Cities Tulsa Tyler Upper Cumberland Upstate South Carolina Vermont – New Hampshire Wabash Valley West Virginia

26

Cash and Cash Equivalents $

985,502 1,552,403 1,060,063 1,650,101 286,432 315,128 337,485 2,072,569 177,412 944,405 1,479,544 138,069 2,575,434 1,834,163 392,218 780,163 472,103 702,267 433,501 174,992 519,890 681,446 160,554 73,445

Investments $

– – – 251,886 – – 20,772 300,000 37,537 200,335 – – 1,750,000 – 130,353 260,985 – – – – 102,492 – – 199,882

Receivables, Net

Prepaid Property and Expenses and Equipment, Other Assets Net

$

$

82,142 436,431 41,037 80,925 14,446 78,587 17,628 209,905 54,113 470,571 165,567 80,843 801,932 518,542 29,245 16,934 39,047 18,152 55,469 5,478 89,222 139,890 6,913 95,379

1,333 – 500 14,753 1,061 7,138 605 6,296 – 19,577 – 800 3,892 6,485 1,873 11,956 – 5,805 – – – – 5,962 7,542

$

1,256 911 15,494 8,700 – – – 23,893 – 22,370 640 1,012 158 5,450 – 1,980 2,261 380 – – 1,441 – – 1,789

Total Assets $

1,070,233 1,989,745 1,117,094 2,006,365 301,939 400,853 376,490 2,612,663 269,062 1,657,258 1,645,751 220,724 5,131,416 2,364,640 553,689 1,072,018 513,411 726,604 488,970 180,470 713,045 821,336 173,429 378,037

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Statement of Financial Position by Affiliate (continued) March 31, 2010

Affiliate Name Western New York Wichita Falls Wyoming Headquarters Eliminations Consolidated

27

Cash and Cash Equivalents $

668,260 189,547 528,166 128,796,504 116,651,817 – $ 245,448,321

Investments – – – 17,576,346 103,856,678 – $ 121,433,024 $

Receivables, Net $

Prepaid Property and Expenses and Equipment, Other Assets Net

241,705 $ 827 6,995 162 10,752 – 30,270,472 784,213 71,963,196 4,665,438 (21,824,759) – $ 80,408,909 $ 5,449,651

– – 427 510,175 4,779,627 – $ 5,289,802 $

Total Assets $

910,792 196,704 539,345 177,937,710 301,916,756 (21,824,759) $ 458,029,707

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Statement of Financial Position by Affiliate (continued) March 31, 2010

Affiliate Name Acadiana Arkansas Aspen Austin Baton Rouge Bayou Region Boise Brainerd Lakes Central Florida Central Georgia Central MS Steel Magnolias Central New Mexico Central New York Central Oklahoma Central & South Jersey Central Texas Central Valley Central Wisconsin Charlotte Chattanooga Chicagoland Area

28

Accounts Payable and Accrued Expenses $

20,473 22,148 6,483 8,568 5,091 9,521 6,165 – 2,096 1,745 987 7,460 7,763 7,907 86,740 807 1,507 – 7,125 10,000 19,828

Deferred Revenue $

– – 2,380 – – – 47,190 – – – 19,165 – 39,791 – 3,100 28,628 – – 825 – –

Grants Payable $

364,735 589,065 37,443 999,474 357,681 214,950 212,507 125,000 824,800 149,419 297,229 200,000 398,432 699,397 1,435,665 137,500 402,140 101,366 1,139,587 197,486 1,385,475

Komen Payable $

109,821 11,038 23,466 111,844 138,576 7,793 54,959 6,512 61,265 16,725 29,438 26,576 73,759 18,010 28,608 18,281 92,670 22,782 105,014 – 144,966

Total Liabilities $

495,029 622,251 69,772 1,119,886 501,348 232,264 320,821 131,512 888,161 167,889 346,819 234,036 519,745 725,314 1,554,113 185,216 496,317 124,148 1,252,551 207,486 1,550,269

Total Net Assets $

156,440 507,862 521,368 951,822 302,253 26,381 430,203 71,708 257,340 164,409 189,770 157,784 366,207 376,730 980,049 623,912 154,083 97,213 561,130 153,349 1,333,389

Total Liabilities and Net Assets $

651,469 1,130,113 591,140 2,071,708 803,601 258,645 751,024 203,220 1,145,501 332,298 536,589 391,820 885,952 1,102,044 2,534,162 809,128 650,400 221,361 1,813,681 360,835 2,883,658

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Statement of Financial Position by Affiliate (continued) March 31, 2010

Affiliate Name Coastal Georgia Coeur d’ Alene Colorado Springs Columbus Connecticut Dallas County Denver Metropolitan Des Moines Eastern Washington Elmira El Paso Florida Suncoast Grand Rapids Greater Amarillo Greater Atlanta Greater Cincinnati Greater Evansville Greater Kansas City Greater Lansing Greater Nashville Greater New York City

29

Accounts Payable and Accrued Expenses $

– 263 5,051 23,794 7,528 40,913 97,427 1,849 6,295 2,833 5,573 4,703 76,215 5,137 35,026 11,909 5,501 30,523 14,352 16,082 42,922

Deferred Revenue $

26,399 – – 177,539 14,890 – – – 94,707 2,205 – 1,698 – – 75,745 – 150 5,725 34,897 – 55,830

Grants Payable $

112,504 2,892 625,307 1,455,765 1,031,148 1,849,726 2,843,566 718,189 428,055 65,112 390,000 1,159,950 339,100 308,811 2,301,873 591,738 476,415 844,249 153,695 672,394 3,142,500

Komen Payable $

28,687 10,854 31,367 126,906 83,864 378,026 137,532 27,202 66,839 15,419 127,205 126,374 22,310 13,051 436,459 210,717 21,600 34,168 210,511 9,811 120,507

Total Liabilities $

167,590 14,009 661,725 1,784,004 1,137,430 2,268,665 3,078,525 747,240 595,896 85,569 522,778 1,292,725 437,625 326,999 2,849,103 814,364 503,666 914,665 413,455 698,287 3,361,759

Total Net Assets $

114,607 273,214 167,183 1,101,934 554,886 912,046 3,368,601 520,447 288,421 144,148 323,468 849,588 220,571 122,544 1,289,469 502,259 409,377 394,644 510,070 418,610 3,182,806

Total Liabilities and Net Assets $

282,197 287,223 828,908 2,885,938 1,692,316 3,180,711 6,447,126 1,267,687 884,317 229,717 846,246 2,142,313 658,196 449,543 4,138,572 1,316,623 913,043 1,309,309 923,525 1,116,897 6,544,565

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Statement of Financial Position by Affiliate (continued) March 31, 2010

Affiliate Name Greater Richmond Greater Roanoke Hawaii Houston Indianapolis Inland Empire Knoxville Las Vegas Lexington Los Angeles County Louisville Lowcountry (Charleston) Lubbock Area Madison Maine Maryland Massachusetts McLean County Memphis Mid-South Miami – Ft. Lauderdale Mid-Kansas

30

Accounts Payable and Accrued Expenses $

5,610 425 2,067 34,805 64,247 6,002 21,993 16,415 1,631 75,997 4,857 8,698 8,843 7,064 29,672 28,493 27,484 10,216 – 4,107 10,741

Deferred Revenue $

60,525 49,545 – – 656,331 – – 69,401 – – – – – 24,070 – 5,430 11,100 – – – –

Grants Payable $

306,383 140,115 280,506 3,524,447 1,219,941 519,850 513,838 652,000 528,645 316,000 617,974 295,210 350,544 613,034 258,856 2,107,796 900,746 98,089 851,358 973,762 904,841

Komen Payable $

50,001 38,503 4,210 83,280 202,585 34,403 – 73,130 13,672 183,824 77,357 187,340 40,779 81,357 16,734 181,094 68,684 19,595 35,458 572,142 25,228

Total Liabilities $

422,519 228,588 286,783 3,642,532 2,143,104 560,255 535,831 810,946 543,948 575,821 700,188 491,248 400,166 725,525 305,262 2,322,813 1,008,014 127,900 886,816 1,550,011 940,810

Total Net Assets $

546,947 196,439 181,523 1,269,272 1,109,209 429,354 295,803 1,195,844 188,197 1,207,840 336,693 469,355 218,428 766,649 244,520 1,614,275 621,797 104,626 145,583 566,356 316,284

Total Liabilities and Net Assets $

969,466 425,027 468,306 4,911,804 3,252,313 989,609 831,634 2,006,790 732,145 1,783,661 1,036,881 960,603 618,594 1,492,174 549,782 3,937,088 1,629,811 232,526 1,032,399 2,116,367 1,257,094

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Statement of Financial Position by Affiliate (continued) March 31, 2010

Affiliate Name Mid-Missouri Milwaukee Minnesota Montana NC Foothills NC Triad NC Triangle Nebraska New Orleans North Central Alabama North Colorado North Dakota North Florida North Jersey North Mississippi North Texas Northeast Louisiana Northeast Ohio Northeast Pennsylvania Northeastern New York Northern Indiana

31

Accounts Payable and Accrued Expenses $

– 44,842 23,655 5,653 146 8,588 16,040 14,628 6,102 11,640 – – 10,851 32,215 666 3,814 368 62,614 16,651 1,332 801

Deferred Revenue $

1,075 – 20,165 3,510 – 68,345 67,672 – – – – – – 106,025 – 25,942 – – – – 14,722

Grants Payable $

80,997 698,848 1,699,190 109,787 150,000 560,234 1,180,000 485,636 514,177 549,995 – – 289,954 968,707 89,000 807,500 214,385 1,582,373 399,330 266,889 172,684

Komen Payable $

27,000 29,698 117,701 9,856 5,295 66,431 69,823 62,823 5,210 11,530 – 3,710 30,138 109,269 46,829 85,824 18,341 184,324 44,105 11,358 44,106

Total Liabilities $

109,072 773,388 1,860,711 128,806 155,441 703,598 1,333,535 563,087 525,489 573,165 – 3,710 330,943 1,216,216 136,495 923,080 233,094 1,829,311 460,086 279,579 232,313

Total Net Assets $

146,140 3,129,185 1,252,393 283,098 67,481 639,290 1,478,420 472,476 248,769 384,290 – 156,318 82,157 2,098,441 59,868 840,825 7,507 656,843 175,734 105,619 93,690

Total Liabilities and Net Assets $

255,212 3,902,573 3,113,104 411,904 222,922 1,342,888 2,811,955 1,035,563 774,258 957,455 – 160,028 413,100 3,314,657 196,363 1,763,905 240,601 2,486,154 635,820 385,198 326,003

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Statement of Financial Position by Affiliate (continued) March 31, 2010

Affiliate Name Northern Nevada Northwest Ohio Orange County Oregon & SW Washington Ozark Peoria Memorial Philadelphia Phoenix Pittsburgh Puget Sound Quad Cities Sacramento Valley Salt Lake City San Antonio San Diego San Francisco Bay Area Shreveport – Bossier City Siouxland South Dakota Southeast Iowa Southern Arizona

32

Accounts Payable and Accrued Expenses $

(1) $ 21,967 71,858 81,803 17,500 7,710 45,647 21,151 9,731 99,187 499 16,604 1,437 8,486 15,125 8,536 3,715 1,509 – – 9,453

Deferred Revenue – – 49,630 – 140,654 65,862 195,023 – 142,090 48,323 347 74,165 40,611 299,989 – – – 7,582 – – 245,971

Grants Payable $

377,590 479,534 960,970 1,046,532 722,672 844,504 2,020,777 1,752,685 1,075,747 2,200,002 192,635 904,066 591,431 849,999 540,000 942,569 189,486 217,941 248,046 147,081 287,314

Komen Payable $

15,212 24,787 63,809 34,555 109,093 101,140 126,948 79,674 182,396 294,712 26,696 109,648 109,392 74,857 44,954 51,925 5,156 7,262 17,063 6,555 121,769

Total Liabilities $

392,801 526,288 1,146,267 1,162,890 989,919 1,019,216 2,388,395 1,853,510 1,409,964 2,642,224 220,177 1,104,483 742,871 1,233,331 600,079 1,003,030 198,357 234,294 265,109 153,636 664,507

Total Net Assets $

151,925 603,257 2,089,725 4,024,308 944,692 891,616 4,912,186 958,795 1,599,545 2,124,039 401,576 1,490,771 327,362 756,414 517,015 1,003,335 103,582 166,559 111,381 115,426 992,751

Total Liabilities and Net Assets $

544,726 1,129,545 3,235,992 5,187,198 1,934,611 1,910,832 7,300,581 2,812,305 3,009,509 4,766,263 621,753 2,595,254 1,070,233 1,989,745 1,117,094 2,006,365 301,939 400,853 376,490 269,062 1,657,258

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Statement of Financial Position by Affiliate (continued) March 31, 2010

Affiliate Name South Florida Southwest Florida Southwest Michigan St. Louis Tarrant County Texarkana Tidewater Tri Cities Tulsa Tyler Upper Cumberland Upstate South Carolina Vermont – New Hampshire Wabash Valley West Virginia Western New York Wichita Falls Wyoming Headquarters Eliminations Consolidated

33

Accounts Payable and Accrued Expenses $

31,935 58,596 9,985 35,249 15,266 2,565 6,881 4,490 6,741 827 345 7,913

6,271 – 6,093 10,454 – 4,463 1,946,274 18,186,318 – $ 20,132,592

Deferred Revenue

Grants Payable

Komen Payable

Total Liabilities

– – 7,361 59,191 140,628 – – – – 14,165 – –

$ 1,359,440 844,254 – 3,121,745 747,500 406,753 601,807 355,083 447,730 272,250 94,273 335,000

$

15,000 – 5,415 31,999 – 360 3,399,088 2,681,525 – $ 6,080,613

557,866 100,000 232,464 387,535 147,927 393,820 83,572,989 185,012,311 – $268,585,300

52,880 6,949 25,437 34,079 12,511 14,859 9,687,023 12,137,736 (21,824,759) $ – $

$

394,043 329,835 30,930 320,863 247,854 11,519 169,669 13,623 58 46,389 1,755 51,908

$

1,785,418 1,232,685 48,276 3,537,048 1,151,248 420,837 778,357 373,196 454,529 333,631 96,373 394,821

Total Net Assets $

827,245 413,066 172,448 1,594,368 1,213,392 132,852 293,661 140,215 272,075 155,339 84,097 318,224

632,017 189,319 106,949 66,480 269,409 108,628 464,067 446,725 160,438 36,266 413,502 125,843 98,605,374 79,332,336 218,017,890 83,898,866 (21,824,759) – 294,798,505 $ 163,231,202

Total Liabilities and Net Assets $

2,612,663 1,645,751 220,724 5,131,416 2,364,640 553,689 1,072,018 513,411 726,604 488,970 180,470 713,045

821,336 173,429 378,037 910,792 196,704 539,345 177,937,710 301,916,756 (21,824,759) $ 458,029,707

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Schedule of Revenue by Affiliate Year Ended March 31, 2010

Affiliate Acadiana Arkansas Aspen Austin Baton Rouge Bayou Region Boise Brainerd Lakes Central & South Jersey Central Florida Central Georgia Central MS Steel Magnolias Central New Mexico Central New York Central Oklahoma Central Texas Central Valley Central Wisconsin Charlotte Chattanooga Chicagoland Area Coastal Georgia Coeur d’ Alene

34

Race for the Cure

Contributions $

121,295 367,917 751,195 590,050 184,752 112,095 171,481 86,309 1,122,941 530,120 114,280 185,868 228,684 440,218 418,976 327,210 148,679 136,815 781,120 95,420 1,404,525 110,500 89,465

$

646,348 2,743,214 251,720 3,210,076 681,642 132,029 909,740 129,220 1,770,165 958,986 332,079 294,729 466,744 724,654 1,209,179 467,327 465,931 41,816 1,722,601 571,195 1,592,727 261,248 137,710

Direct Benefits $

38,023 304,440 39,381 319,978 8,122 8,334 154,783 12,666 187,067 84,585 42,816 6,286 10,447 54,435 151,597 69,403 29,295 7,205 124,950 59,909 112,036 18,341 17,088

Interest, Dividends, Gains

Other Fundraising $

4,000 5,200 6,200 5,200 5,200 5,200 4,000 4,000 5,200 9,110 5,000 5,200 6,200 1,200 5,200 5,200 5,200 5,200 6,200 4,000 5,200 6,200 5,200

$

5,596 17,456 10,211 654 1,077 153 9,179 141 16,424 6,904 3,907 169 2,331 851 5,908 3,008 2,704 1,792 13,042 707 23,106 4,555 1,519

Total Net Revenue

Other $

10,733 57,354 3,431 – 6,755 667 5,786 1,247 11,274 1,048 3,574 2,178 788 12,525 442 3,458 6,795 20 12,013 15,277 2,118 – 4,521

$

749,949 2,886,701 983,376 3,486,002 871,304 241,810 945,403 208,251 2,738,937 1,421,583 416,024 481,858 694,300 1,125,013 1,488,108 736,800 600,014 178,438 2,410,026 626,690 2,915,640 364,162 221,327

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Schedule of Revenue by Affiliate (continued) Year Ended March 31, 2010

Affiliate Colorado Springs Columbus Connecticut Dallas County Denver Metropolitan Des Moines Eastern Washington El Paso Elmira Florida Suncoast Grand Rapids Greater Amarillo Greater Atlanta Greater Cincinnati Greater Evansville Greater Kansas City Greater Lansing Greater Nashville Greater New York City Greater Richmond Greater Roanoke Hawaii Houston

35

Race for the Cure

Contributions $

234,391 582,333 860,365 655,243 1,535,179 555,346 185,220 312,602 95,094 1,077,997 228,310 189,615 1,720,972 629,239 323,484 512,463 346,767 438,349 1,744,490 473,188 144,022 113,865 1,494,208

$

721,471 2,734,555 1,297,010 3,771,373 8,059,873 1,392,069 575,412 886,577 129,795 1,234,587 605,615 383,882 1,916,758 1,296,120 1,496,163 1,554,743 635,168 1,525,184 8,715,930 965,227 174,370 561,645 5,637,331

Direct Benefits $

113,943 270,103 128,578 269,553 613,453 121,540 63,291 54,283 3,252 146,460 58,134 29,268 116,591 151,506 141,835 114,527 33,482 144,612 755,023 105,250 3,782 80,875 492,282

Interest, Dividends, Gains

Other Fundraising $

2,200 8,300 5,200 12,200 7,700 6,200 5,200 5,200 5,200 5,200 5,709 4,000 5,200 2,200 5,200 7,185 5,200 5,200 7,700 5,200 6,200 9,200 5,200

$

3,890 18,045 1,028 12,215 116,270 2,755 5,555 1,770 1,458 6,355 6,275 1,421 1,513 12,104 10,699 15,205 5,554 8,509 7,150 2,124 511 2,229 14,233

Total Net Revenue

Other $

26,363 – 7,740 46,798 – – 9,786 4,977 4,086 – 9,196 3,632 5 2,926 – – 36 27,725 -4,226 15,485 2,534 38,278 –

$

874,372 3,073,130 2,042,765 4,228,276 9,105,569 1,834,830 717,882 1,156,843 232,381 2,177,679 796,971 553,282 3,527,857 1,791,083 1,693,711 1,975,069 959,243 1,860,355 9,716,021 1,355,974 323,855 644,342 6,658,690

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Schedule of Revenue by Affiliate (continued) Year Ended March 31, 2010

Affiliate

Contributions

Indianapolis $ 732,195 Inland Empire 369,612 Knoxville 322,993 Las Vegas 406,105 Lexington 449,513 Los Angeles County 1,036,188 Louisville 484,145 Lowcountry (Charleston) 359,556 Lubbock Area 339,252 Madison 382,484 Maine 322,052 Maryland 1,318,216 Massachusetts 1,128,335 McLean County 153,323 Memphis Mid-South 240,311 Miami – Ft. Lauderdale 606,370 Mid-Kansas 305,228 Mid-Missouri 171,192 Milwaukee 2,374,172 Minnesota 820,425 Montana 130,583 NC Foothills 93,496 NC Triad 277,715

36

Race for the Cure $ 3,244,099 1,496,049 1,160,855 1,651,206 570,646 2,132,656 809,227 1,023,704 575,121 1,170,448 432,624 5,413,081 889,785 – 1,317,449 2,102,353 556,075 28,626 1,877,357 3,715,125 288,860 180,464 1,168,739

Direct Benefits $

342,491 123,250 109,020 121,900 88,839 184,210 141,619 86,213 32,778 109,508 42,237 231,773 23,942 5,950 115,471 57,056 52,885 3,157 104,969 325,530 30,702 8,730 84,244

Interest, Dividends, Gains

Other Fundraising $

5,200 5,200 6,000 5,200 7,200 5,200 6,200 1,200 5,200 5,200 9,250 5,200 5,200 5,200 4,000 5,200 1,200 5,200 5,200 5,200 6,200 5,000 6,200

$

16,504 2,744 7,101 16,971 7,046 5,463 7,320 1,999 4,358 8,018 1,279 18,412 17,428 1,901 5,703 3,199 168 2,159 2,255 2,425 266 375 4,043

Other $

75 2,941 4,386 14,571 3,899 12,972 37,403 11,943 19,402 11,151 8,077 3,153 – 5 8,179 5 18,469 320 – 39,971 2,673 – 13,999

Total Net Revenue $ 3,655,582 1,753,296 1,392,315 1,972,153 949,465 3,008,269 1,202,676 1,312,189 910,555 1,467,793 731,045 6,526,289 2,016,806 154,479 1,460,171 2,660,071 828,255 204,340 4,154,015 4,257,616 397,880 270,605 1,386,452

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Schedule of Revenue by Affiliate (continued) Year Ended March 31, 2010

Affiliate NC Triangle Nebraska New Orleans North Central Alabama North Colorado North Dakota North Florida North Jersey North Mississippi North Texas Northeast Louisiana Northeast Ohio Northeast Pennsylvania Northeastern New York Northern Indiana Northern Nevada Northwest Ohio Orange County Oregon & SW Washington Ozark Peoria Memorial Philadelphia Phoenix

37

Contributions $

Race for the Cure

513,563 379,317 323,606 319,083 – 161,087 490,506 1,599,238 105,176 415,182 76,031 1,017,959 369,594 171,350 132,858 158,760 418,031 1,760,384

$ 2,066,869 998,989 464,617 1,304,822 – – 676,947 3,722,910 199,620 1,576,356 218,684 2,189,463 466,683 343,672 143,783 558,811 1,097,775 3,715,744

1,132,555 591,973 480,990 2,137,426 974,808

3,890,563 1,368,916 1,260,048 6,013,632 3,316,956

Direct Benefits $

221,862 94,826 46,356 65,014 – – 54,221 259,943 5,921 190,553 23,268 224,174 94,137 27,091 7,695 61,425 107,037 325,425 282,576 117,431 170,790 626,899 132,137

Interest, Dividends, Gains

Other Fundraising $

773,240 1,200 5,200 6,700 – 6,200 1,200 5,200 5,200 4,600 5,200 6,200 5,200 5,000 5,200 6,200 5,200 5,200 131,450 5,200 5,200 4,000 5,200

$

14,161 2,632 911 6,546 11 126 4,425 1,645 805 5,994 – 12,008 3,173 4,329 231 3,826 9,997 28,360 11,666 12,259 15,828 4,583 200

Other $

Total Net Revenue

3,013 8,861 131 528 – – 7,574 80,374 2,708 25,119 – – 4,043 5,193 9,867 22,054 23,413 –

$ 3,148,984 1,296,173 748,109 1,572,665 11 167,413 1,126,431 5,149,424 307,588 1,836,698 276,647 3,001,456 754,556 502,453 284,244 688,226 1,447,379 5,184,263

55,938 – 45,340 39,028 11,300

4,939,596 1,860,917 1,636,616 7,571,770 4,176,327

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Schedule of Revenue by Affiliate (continued) Year Ended March 31, 2010

Affiliate Pittsburgh Puget Sound Quad Cities Sacramento Valley Salt Lake City San Antonio San Diego San Francisco Bay Area Shreveport – Bossier City Siouxland South Dakota South Florida Southeast Iowa Southern Arizona Southwest Florida Southwest Michigan St. Louis Tarrant County Texarkana Tidewater Tri Cities Tulsa Tyler

38

Contributions $

Race for the Cure

705,505 2,537,006 140,731 436,881 203,765 338,062 607,153 1,028,855

$ 3,072,608 2,299,597 540,680 2,592,558 780,130 2,073,067 1,462,829 1,256,736

130,381 110,379 154,210 907,837 72,886 442,435 739,450 136,589 1,129,729 600,373 98,997 631,611 159,344 222,302 108,402

475,762 324,501 353,707 2,413,929 120,644 1,511,667 1,229,638 340,229 4,386,340 2,012,459 563,659 1,067,804 504,051 1,075,322 417,738

Direct Benefits $

282,303 210,905 56,016 183,794 67,083 221,345 147,734 47,027 9,374 44,787 26,319 176,698 6,373 90,938 25,871 36,369 204,195 68,450 73,231 112,434 37,994 128,501 38,542

Interest, Dividends, Gains

Other Fundraising $

5,200 5,200 5,200 5,200 6,200 5,200 5,200 5,200 5,200 5,200 6,200 4,000 4,000 5,200 7,100 6,200 5,200 4,600 5,200 5,200 5,200 5,200 5,000

$

30,178 30,362 965 2,543 5,331 3,119 6,163 4,220 428 279 595 25,255 10,503 7,170 10,128 1,077 33,742 2,130 7,950 12,439 368 3,421 1,954

Other $

Total Net Revenue

20 12,505 19,101 5 5,952 – 5 1,693

$ 3,531,208 4,673,765 650,661 2,853,393 934,295 2,198,103 1,933,616 2,249,677

– 51,405 2,868 6,197 89 7,599 4,652 4,236 15,580 – – 27,507 501 10,369 3,349

602,397 446,977 491,261 3,180,520 201,749 1,883,133 1,965,097 451,962 5,366,396 2,551,112 602,575 1,632,127 631,470 1,188,113 497,901

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Schedule of Revenue by Affiliate (continued) Year Ended March 31, 2010

Affiliate Upper Cumberland Upstate South Carolina Vermont-New Hampshire Wabash Valley West Virginia Western New York Wichita Falls Wyoming Headquarters Eliminations Total Revenue

39

Race for the Cure

Contributions $

149,911 407,405

$

91,115 1,119,225

337,801 493,033 111,211 163,881 197,943 359,567 233,158 660,189 115,387 137,783 236,701 248,281 62,957,995 167,541,076 174,713,521 11,214,990 (34,503,943) – $ 203,167,573 $ 178,756,066

Direct Benefits $

16,126 $ 38,745

66,173 30,864 42,148 27,272 14,024 31,571 14,001,271 5,880,580 – $ 19,881,851 $

Other Fundraising 6,200 $ 2,125

Interest, Dividends, Gains 472 $ 4,399

Total Net Revenue

Other 2,185 60

5,200 1,652 3,486 5,200 267 4,862 6,200 993 5,775 5,200 5,785 – 5,200 91 3,096 1,200 2,108 898 1,535,569 885,202 1,109,418 1,392,146 28,597,088 7,220,380 – – (1,886,238) 2,927,715 $ 29,482,290 $ 6,443,560

$

233,757 1,494,469

774,999 254,557 528,330 877,060 247,533 457,617 220,027,989 217,257,545 (36,390,181) $ 400,895,353

1009-1188665

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Schedule of Functional Expenses by Affiliate Year Ended March 31, 2010

Affiliate Acadiana Arkansas Aspen Austin Baton Rouge Bayou Region Boise Brainerd Lakes Central & South Jersey Central Florida Central Georgia Central MS Steel Magnolias Central New Mexico Central New York Central Oklahoma Central Texas Central Valley Central Wisconsin Charlotte Chattanooga Chicagoland Area Coastal Georgia Coeur d’ Alene Colorado Springs Columbus Connecticut Dallas County Denver Metropolitan Des Moines Eastern Washington El Paso Elmira Florida Suncoast Grand Rapids Greater Amarillo Greater Atlanta Greater Cincinnati

1009-1188665

Research $ 109,734 415,624 131,526 478,657 138,576 32,752 152,080 28,401 483,276 218,844 62,910 55,666 66,390 172,509 249,739 61,278 92,670 22,749 467,442 94,545 377,703 59,500 24,085 136,534 574,464 299,683 648,056 1,094,526 243,841 119,113 122,091 29,611 363,833 126,282 86,169 628,107 459,924

Program Services Health Public Health Screening Education Services $ 245,198 $ 170,528 924,412 1,073,943 192,124 31,883 1,693,334 253,604 161,837 154,194 78,425 83,675 352,486 319,518 90,288 5,000 1,506,193 534,720 360,689 630,563 122,182 158,904 209,369 112,542 277,704 53,375 432,472 123,076 677,643 319,109 63,866 177,944 361,527 11,067 41,580 76,279 548,623 716,100 272,996 182,319 1,485,413 516,623 192,554 86,157 30,223 11,000 286,228 272,340 1,077,593 937,733 1,028,059 413,701 1,095,339 893,182 2,493,447 1,423,065 457,725 670,295 286,904 162,476 616,562 63,767 71,625 44,128 440,661 967,431 288,191 149,204 159,682 143,590 800,267 1,764,947 446,463 329,496

Supporting Services General and Administrative Treatment Services $ 113,857 58,951 1,894 324,670 52,746 49,557 32,863 54,468 – 123,528 5,437 – 79,850 75,448 – 78,000 85,348 – 284,659 31,015 160,424 – – 244,014 162,609 33,000 1,047,075 1,280,022 – 50,286 110,183 38,445 127,601 73,965 119,851 -71,653 203,112

Fundraising $ 60,718 302,572 199,778 350,472 220,615 17,050 72,231 11,700 99,465 115,965 21,128 12,936 83,961 72,986 112,532 25,666 37,299 12,915 92,141 40,685 263,742 16,324 17,517 82,611 159,523 159,657 368,860 1,033,709 118,154 27,115 106,786 4,999 131,294 58,664 28,926 202,182 110,811

Employee Cost $ 7,659 109,954 41,863 103,676 9,909 1,628 36,787 443 208,683 37,009 5,661 20,134 56,632 101,859 49,373 12,544 37,810 7,336 104,616 5,501 312,607 6,983 9,096 20,074 78,068 124,802 31,928 92,026 27,110 35,724 22,622 416 83,231 46,771 7,845 227,886 117,036

Occupancy $ 7,988 1,494 6,577 21,752 7,072 1,205 8,159 3,143 47,807 13,376 7,080 29,793 14,955 9,701 16,395 21,238 3,146 608 24,259 4,695 47,077 11,425 1,839 17,442 14,835 6,582 26,784 13,009 24,027 9,018 13,041 1,071 9,500 6,812 28,038 55,238 20,223

Postage and Shipping $ 2,670 1,307 1,392 1,573 125 – 428 120 2,686 667 355 279 887 8,927 1,749 532 1,592 313 1,658 119 4,121 167 120 485 5,969 2,017 636 1,864 1,811 267 334 805 372 746 98 2,962 423

Printing and Professional Publication Fees $ 3,792 $ 5 844 3,776 7,190 8,538 -1,209 12,278 196 7,078 1,382 2,100 1,390 957 62 193 21,032 21,355 2,458 20,906 1,032 – 289 1,536 311 5,836 5,019 2,160 1,993 566 3,109 3,752 111 215 1,396 – 190 2,887 260 4,853 3,824 82,106 60 240 1,671 – 820 3,751 11,255 4,495 2,414 33,841 1,189 9,000 8,231 41,793 378 753 – 4,534 205 11,875 353 950 15,248 7,716 454 87 43 114 2,208 9,859 1,162 573

$

Other 5,281 8,759 8,717 23,792 3,815 1,280 6,684 889 52,870 7,780 2,864 2,133 4,197 17,363 5,177 3,136 6,104 1,964 12,213 2,201 11,887 4,963 1,699 4,335 7,903 18,816 25,810 42,880 23,745 1,868 5,668 1,738 6,051 9,778 1,090 14,868 24,809

Total Expenses $ 727,430 2,901,636 631,482 3,262,599 756,163 269,054 983,583 194,707 2,978,087 1,531,785 387,553 444,677 644,098 1,021,520 1,434,276 451,065 636,889 165,140 2,254,788 639,189 3,265,527 378,373 97,250 1,068,634 3,034,447 2,122,572 4,147,859 7,524,572 1,567,839 697,305 1,073,134 194,141 2,152,938 760,954 575,446 3,636,871 1,714,032

40

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Schedule of Functional Expenses by Affiliate (continued) Year Ended March 31, 2010

Affiliate Greater Evansville Greater Kansas City Greater Lansing Greater Nashville Greater New York City Greater Richmond Greater Roanoke Hawaii Houston Indianapolis Inland Empire Knoxville Las Vegas Lexington Los Angeles County Louisville Lowcountry (Charleston) Lubbock Area Madison Maine Maryland Massachusetts McLean County Memphis Mid-South Miami – Ft. Lauderdale Mid-Kansas Mid-Missouri Milwaukee Minnesota Montana NC Foothills NC Triad NC Triangle Nebraska New Orleans North Central Alabama North Colorado

1009-1188665

Research $ 215,371 315,194 234,700 279,284 1,321,663 224,854 34,840 96,159 1,186,667 540,373 205,201 213,180 226,726 151,327 181,324 202,111 171,563 151,438 237,549 106,306 877,992 335,134 19,595 259,153 411,022 116,730 24,028 294,732 561,210 44,376 38,879 189,704 421,346 235,386 136,011 236,070 20,225

Program Services Health Public Health Screening Education Services $ 751,875 $ 286,262 572,758 655,920 362,393 110,167 863,494 236,683 4,182,213 1,358,829 478,945 378,553 67,517 76,032 209,554 149,140 1,089,112 2,601,572 1,421,238 948,999 844,894 – 535,422 222,989 782,258 200,709 110,778 31,615 1,306,790 238,958 522,313 84,001 619,179 205,830 326,179 109,959 640,984 158,464 242,366 84,161 3,007,647 534,623 1,368,041 169,790 120,816 13,000 481,797 566,512 996,773 621,714 411,824 227,715 108,209 44,165 726,405 117,515 1,931,917 568,529 136,312 102,196 56,141 97,018 444,326 371,668 1,293,287 625,694 383,106 227,912 111,479 319,553 628,743 360,832 55,754 –

Supporting Services General and Administrative Treatment Services $ 87,002 123,256 76,244 104,603 1,237,230 44,240 – 43,073 776,499 19,742 334,426 96,264 326,114 476,251 153,981 163,589 48,414 92,481 119,669 55,839 784,171 – – 68,652 102,142 50,000 40,803 36,724 253,187 – 33,826 98,450 59,020 178,186 67,327 (10,000) –

Fundraising $ 189,097 154,780 51,189 168,278 1,196,629 90,774 9,695 31,522 483,057 327,762 190,649 116,140 179,015 60,068 791,655 121,248 96,859 59,408 73,967 51,215 567,410 144,358 12,006 92,567 228,811 54,417 11,529 191,284 403,709 32,535 7,375 112,741 302,264 73,473 41,004 135,219 –

Employee Cost $ 53,979 55,110 69,405 100,221 205,763 65,325 18,893 30,636 268,426 141,601 71,730 82,173 58,269 83,538 237,578 61,737 21,213 52,530 46,285 74,089 208,943 49,035 1,928 24,696 42,560 59,091 2,780 6,965 54,830 20,553 1,963 80,634 131,627 96,044 13,254 48,592 –

Occupancy $ 7,731 8,830 24,511 19,636 48,950 9,479 8,690 22,010 48,046 37,979 21,470 13,915 14,111 22,929 103,615 13,487 35,410 55,101 15,579 12,294 27,655 16,437 1,167 1,363 14,028 40,341 3,337 17,802 5,269 3,025 8,952 62,842 46,035 27,706 9,850 8,457 43

Postage and Shipping $ 1,492 389 655 491 7,067 1,536 137 -445 5,021 963 297 734 1,534 463 1,502 416 394 1,185 919 665 1,235 438 559 257 490 584 30 685 2,164 169 465 92 3,259 300 261 501 –

Printing and Professional Publication Fees $ 18,909 $ 3,160 81 2,015 1,986 6,660 784 5,311 3,301 22,012 3,626 3,367 110 80 2,021 6,348 9,896 31,759 2,248 36,488 207 3,574 1,422 1,510 5,404 3,508 840 2,673 6,746 73,844 283 11,169 709 11,472 4,627 3,613 1,103 8,934 631 3,331 709 62,793 1,823 44,576 275 – – 52 9,808 – 338 14,816 179 2,658 1,701 66,327 – 7,883 138 – – – 1,291 62 1,535 12,237 – – 179 2,023 223 26,939 – –

$

Other 4,182 1,016 5,964 8,796 41,960 7,643 6,853 2,347 17,916 32,344 2,227 6,632 7,188 17,181 16,784 2,896 10,436 11,769 8,872 5,909 8,236 7,680 219 7,160 12,063 6,381 9,804 17,717 1,592 3,161 22,787 10,850 27,490 14,195 4,145 6,327 78

Total Expenses $ 1,619,060 1,889,349 943,874 1,787,581 9,625,617 1,308,342 222,847 592,365 6,517,971 3,509,737 1,674,675 1,290,381 1,804,836 957,663 3,112,777 1,183,250 1,221,479 868,290 1,312,325 636,806 6,081,414 2,137,312 169,565 1,502,209 2,439,411 982,237 247,522 1,477,857 3,790,290 342,465 267,406 1,372,660 2,923,794 1,236,308 705,086 1,441,903 76,100

41

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Schedule of Functional Expenses by Affiliate (continued) Year Ended March 31, 2010

Affiliate North Dakota North Florida North Jersey North Mississippi North Texas Northeast Louisiana Northeast Ohio Northeast Pennsylvania Northeastern New York Northern Indiana Northern Nevada Northwest Ohio Orange County Oregon & SW Washington Ozark Peoria Memorial Philadelphia Phoenix Pittsburgh Puget Sound Quad Cities Sacramento Valley Salt Lake City San Antonio San Diego San Francisco Bay Area Shreveport – Bossier City Siouxland South Dakota South Florida Southeast Iowa Southern Arizona Southwest Florida Southwest Michigan St. Louis Tarrant County Texarkana

1009-1188665

Research $ 3,710 177,991 453,897 46,156 219,154 33,385 575,934 106,426 73,524 24,247 110,736 231,219 789,097 567,870 259,548 283,631 949,287 550,828 523,170 754,712 91,756 380,111 173,433 256,872 283,370 363,169 58,414 44,121 69,181 486,322 17,202 261,502 319,205 71,145 1,027,324 411,788 81,463

Program Services Health Public Health Screening Education Services $ – $ – 466,692 300,566 2,193,702 252,604 73,490 138,929 512,931 231,275 91,905 68,333 1,603,926 553,343 381,260 136,706 323,325 35,453 165,789 21,150 207,710 128,165 558,204 259,214 1,563,482 910,151 1,968,605 792,214 419,373 199,920 392,328 524,170 2,270,636 1,361,950 1,453,006 545,960 1,437,998 796,853 1,746,446 1,051,534 248,287 347,860 927,425 312,521 580,932 115,883 821,522 413,467 732,751 339,591 873,906 140,548 24,461 174,585 116,616 63,484 243,628 89,033 1,366,586 661,962 56,223 9,432 738,296 134,457 671,468 351,709 137,384 92,119 702,485 2,013,833 696,554 882,659 163,732 370,359

Supporting Services General and Administrative Treatment Services $ – 12,823 349,179 15 450,696 105,244 – 70,491 44,528 86,451 182,604 111,742 664,635 103,964 382,372 109,341 – 885,354 201,638 471,925 – 213,583 58,200 374,533 80,804 429,176 – 98,805 52,674 211,726 105,904 243,020 234,508 – 706,902 500,378 4,253

Fundraising $

– 163,073 729,333 9,737 143,426 13,940 153,455 61,148 38,149 15,153 41,872 115,937 502,279 799,660 221,723 63,356 676,022 372,769 286,857 532,240 64,040 192,997 87,925 233,725 123,365 103,648 281,260 32,479 36,547 362,011 14,175 194,071 136,173 26,480 193,116 155,237 44,455

Employee Cost $ 5,385 30,425 208,306 8,991 86,049 5,551 182,464 28,824 14,707 22,567 3,301 32,883 132,595 48,344 141,452 7,193 143,440 154,517 106,119 170,730 10,098 114,748 38,736 37,810 54,629 73,240 14,555 11,531 1,981 75,110 224 35,203 56,518 9,063 193,688 32,925 13,403

Occupancy $ 320 16,172 58,277 7,888 6,514 1,499 29,676 8,160 1,188 21,039 2,538 5,750 99,541 3,605 15,535 25,953 56,987 17,001 17,016 54,164 258 17,509 29,059 9,053 14,060 22,972 6,497 15,987 314 60,770 793 44,541 71,783 8,703 34,701 33,698 2,150

Postage and Shipping $ – 194 4,665 631 178 314 7,769 412 794 839 1,885 1,373 1,586 569 1,001 122 2,199 5,562 3,972 1,172 136 243 1,173 708 2,682 1,332 213 199 144 42 174 1,303 1,699 532 2,179 206 152

Printing and Professional Publication Fees $ 1,250 $ – 561 6,975 6,972 9,236 – 5,683 1,112 1,414 299 11,621 30,789 34,618 4,470 – 724 – 3,448 718 553 6,938 749 12,467 7,594 47,656 966 645 2,928 7,173 369 1,495 126,245 980 22,303 37,073 4,944 21,439 24,481 21,622 124 – 2,312 8,582 1,672 90 761 4,172 6,011 18,504 1,391 37,581 212 500 950 48 69 16,050 152 24,648 – – 421 2,672 1,786 3,259 6,383 8,829 3,355 19,607 77 3,024 30 –

$

Other 430 6,155 26,502 4,143 9,466 3,868 32,126 6,052 3,607 1,368 6,428 7,435 12,094 2,614 10,887 -194 21,939 27,837 24,638 12,099 6,369 8,788 8,706 8,882 35,059 39,521 2,227 885 419 8,725 1,261 7,930 21,365 4,833 5,077 3,338 1,664

Total Expenses $ 11,095 1,181,627 4,292,673 295,663 1,662,215 335,959 3,204,100 803,949 535,999 362,769 692,730 1,336,973 4,730,710 4,289,056 1,661,912 1,407,764 5,609,685 4,072,210 3,424,644 4,841,125 768,928 2,178,819 1,095,809 2,161,505 1,690,826 2,086,484 562,924 385,105 510,040 3,258,054 205,388 1,663,416 1,869,473 365,471 4,902,267 2,719,884 681,661

42

The Susan G. Komen Breast Cancer Foundation, Inc. dba Susan G. Komen for the Cure® and Affiliates Consolidating Schedule of Functional Expenses by Affiliate (continued) Year Ended March 31, 2010

Affiliate Tidewater Tri Cities Tulsa Tyler Upper Cumberland Upstate South Carolina Vermont-New Hampshire Wabash Valley West Virginia Western New York Wichita Falls Wyoming Eliminations Headquarters Total Consolidated

1009-1188665

Program Services Health Public Health Screening Research Education Services $ 158,588 $ 835,077 $ 244,965 104,816 144,496 285,411 174,248 475,695 308,952 92,063 139,508 229,857 27,048 85,480 37,137 164,745 637,705 212,258 118,989 334,158 119,593 26,359 62,271 83,500 82,036 183,942 198,944 127,498 335,116 170,011 35,139 35,462 147,927 59,815 216,912 235,801 31,748,557 78,481,609 44,241,105 (31,576,228) (4,395,677) – $ 75,234,740 $ 66,687,575 $ 2,619,717 $ 75,407,069 $ 140,773,507 $ 46,860,822

Supporting Services General and Administrative Treatment Services $ 130,357 – – 11,000 2,500 – 105,324 10,000 45,990 42,253 – 46,928 19,114,450 – $ 1,023,319 $ 20,137,769

FundEmployee raising Cost $ 271,294 $ 105,449 38,988 13,183 77,936 83,249 -46,826 8,031 40,459 2,547 172,281 87,340 41,048 3,680 19,606 2,267 27,688 8,158 46,399 72,093 11,232 – 63,528 25,559 19,692,864 7,564,159 (8,864) – $ 16,461,613 $ 12,057,814 $ 36,145,613 $ 19,621,973

Occupancy $ 29,655 7,091 16,745 3,708 523 8,038 4,717 12,489 17,353 8,499 -30 2,855 2,327,800 – $ 2,521,503 $ 4,849,303

Postage and Shipping $ 413 1,020 343 865 151 1,792 1,001 263 705 2,844 44 64 145,339 – $ 96,016 $ 241,355

Printing and Professional Publication Fees $ 1,264 $ 5,625 566 900 564 6,820 930 7,208 345 2,224 2,344 2,240 752 12,049 159 2,264 786 185 8,687 90 – – 515 6,660 466,870 1,213,456 $ 2,125,792 $ 2,592,662

$ 5,679,014 $ 6,892,470

Total Other Expenses $ 21,636 $ 1,804,323 2,685 599,156 12,546 1,157,098 2,454 448,798 2,501 200,915 629 1,289,372 1,198 742,509 1,356 220,534 2,468 568,255 7,252 820,742 524 230,298 799 659,436 1,204,518 206,200,727 (409,412) (36,390,181) $ 5,631,204 $ 190,138,307 $ 6,426,310 $ 359,948,853

43

Ernst & Young LLP Assurance | Tax | Transactions | Advisory About Ernst & Young Ernst & Young is a global leader in assurance, tax, transaction and advisory services. Worldwide, our 144,000 people are united by our shared values and an unwavering commitment to quality. We make a difference by helping our people, our clients and our wider communities achieve their potential.

www.ey.com